May, 2007:

Bristol-Myers Squibb pleads guilty to lying about Plavix deal

GSK again on defensive with Avandia

GSK preaches Avandia safety to docs, forgoes new DTC

InVentiv buys brand ID shop Addison Whitney

Court extends restraining order blocking generic Lotrel sales

GSK preaches Avandia safety to docs, forgoes new DTC

Amgen subpoenaed over promotional, marketing, med-ed activities

Elan CEO to pharma: lower cost of new groundbreaking treatments

Mike Lazur, Noesis vets form new agency, Lazur Hoyvald Goldstein Partners

Judge accepts Paxil deal

GSK CEO Garnier says data will ‘vindicate’ Avandia

Amgen subpoenaed over promotional, marketing, med-ed activities

GSK offers New Yorkers an ‘Alli Experience’

AbelsonTaylor, Inc.

Cadient Group

CCA Advertising

Donahoe Purohit Miller Advertising

Flashpoint Medica

Goble & Associates

Interlink Healthcare Communications

JUICE Pharma Advertising

Wyeth’s Lybrel gets FDA nod

Loescher leaving Merck to take Siemens CEO job

Avandia raises heart attack risk: NEJM analysis

Branded Rx dips in ’06 as more generics become available: study

Microsoft to purchase Avenue A | Razorfish parent aQuantive in $6 billion deal

Cobb leaves Pace

Haymarket names Barsamian med-ed unit head

Europe eyes pharma-backed TV channel as industry vies to lift DTC ban

Product news from the 05/22/07 news brief

People news from the 05/22/07 news brief

Company news from the 05/22/07 news brief

Alchemy to be part of Integrated; taps Klein from KPR

FDA delay on Mircera a reprieve for Amgen, J&J

Patient Marketing Group, Inc.

Agency braces for sale of Bausch & Lomb and its eye-care portfolio

Study shows Gardasil guards against vaginal, vulval cancers; Arizona lawmakers block debate over vaccine

FDA panel favors FluMist for young children

Consumers top reaction to DTC ads? Seek more info: survey

‘Unparalleled rise’ in use of diabetes meds by girls: study

Sepracor taps Adams as CEO

CME authorities to consider stepping up vigilance

Senate passes drug-safety bill

J&J, Amgen under fire for anemia drug marketing amid safety concerns

Mylan emerges as victor for Merck KGaA generics business

Purdue Pharma, top execs plead guilty to misleading marketing of OxyContin

In settlement, BMS takes fine for hiding Apotex deal

AstraZeneca awaiting Seroquel XR approval

Texas governor backs off mandatory Gardasil vaccination effort: AP

Product news from the 05/15/07 news brief

Company news from the 05/15/07 news brief

People news from the 05/15/07 news brief

Merck receives approvable letter from FDA for Emend

DTC moratorium out, fines in for Senate PDUFA bill; importation measure checked

More firms say they will divulge CME grants

TV continues to attract pharma’s media spend: Nielsen

Lilly hires HHS’ Azar as top PR

Colucci to head Publicis Healthcare; Goldstone to DDB

MM&M webcast clarifies proper role of CME lectures

Thomson med-ed biz sold to private equity firm

AstraZeneca takes heat over biotech purchase

FDA bolsters black box on antidepressants to warn of suicidality in young adults

Product news from the 05/08/07 News Brief

People news from the 05/08/07 News Brief

Company news from the 05/08/07 News Brief

Patient dies after taking developmental anemia drug: Astellas

FDA bolsters black box on antidepressants to warn of suicidality in young adults

PR View by Laura Perry

Minority outreach pairs docs, clergy

Delta Burke fronts Byetta diabetes awareness tour

Web Watch

FDA warns of buying Accutane online

Novo diabetes site adds new tools to self-manage

Waxman takes tough talk to enemy territory

Cause and effect

Judge jilts Granite State data hatas

Lilly discloses CME grants online

FDA rejects Merck’s Arcoxia

Bristol-Myers Squibb names Cornelius permanent CEO

AstraZeneca to continue seeking pipeline acquisitions, Brennan tells Reuters

FDA eyes Lilly Zyprexa data: NY Times

Pfizer invents a new language in Canadian Viagra reminder ads

FDA adds podcasts on drug safety info

Spending on biotech prescriptions on the rise

Product news from the 05/01/07 news brief

Journal Ad Review: Optical Illusion

People news from the 05/01/07 news brief

Do the Segments Stack Up?

Company news from the 05/01/07 news brief

Conscientious Objectives

The Top 20 Pharma Companies

Cats and Saint Sebastian

Boom time for nonmeasured media?

Headliner: Bil Kennally of Greenstone

Antidote

FDA issues 20 Warning Letters

Promo piece for Provigil lists unapproved uses

Ten priority drugs approved in ’06

FDA: Abbott failed to reveal facts about Prism

House of Reps OKs FOI and whistleblower bills

Lawmakers seek marketing info

FDA tightens advisory group criteria

J&J receives subpoenas

FDA chief says paper misquoted him

As I see it

Digitas rebrands MBC as Digitas Health

Disease awareness ads drive online search

Consumers recall a third of TV drug ads

Big pharma ups consumer ad spend

Celebrex returns to TV with long spot

DTC mistakes cost marketers millions

Centrix to license Target SFA CRM suite

HealthEd hires Collins

Faslodex treatment to be launched by Wunderman

Osteoporosis medication adherence is poor

PDI inks one-year sales agreement

Patient needs come first in RM: Novo

More sales force cuts predicted for ’07

Vantage Point

Firms looking outside-in deliver competitive edge

Decision delayed over NH state Rx data

NYU Medical Center enables training docs to earn CME credit

Skyscape CME 360 launched

Medical Directions says CA docs likely to address domestic violence

Quadrant Medical Education hires Falcetano

Medscape will create journal CME activities

Outcomes researcher moves south to national nonprofit

Space, the final frontier for…med ed?

Chest ranked as leading medical journal among pulmonologists

Kinetic launches healthcare practice

Longtime publisher Krakoff dies

AMP rebrands to Association of Medical Media

JAMA sales exec wins Nexus glory

JAAPA redesign highlights readability